Determination of Lamotrigine in Human Serum by High-performance Liquid Chromatography–tandem Mass Spectrometry
Overview
Affiliations
A rapid and sensitive liquid chromatography–tandem mass spectrometry method was developed and validated for quantification of lamotrigine in human serum. After a simple protein precipitation using acetonitrile, the analytes were separated on a Shideido 150 mm × 2.0 mm, 5 μm Capcell Pak C18 MG column using 70% acetonitrileas mobile phase at a flow rate of 200 μl/min. Lamotrigine was eluted at 1.98 min, ionized using electrospray ionization source, and then detected by multiple reaction monitoring mode. The precursor to product ion transitions of m/z 256.1–109.0 was used to quantify. The analytical measurement range is from 0.1 to 20 μg/ml and the upper clinical reportable range is chosen to be 100 μg/ml. The method was successfully employed in a clinical application.
Ghatol S, Vithlani V, Gurule S, Khuroo A, Monif T, Partani P J Pharm Anal. 2018; 3(2):75-83.
PMID: 29403800 PMC: 5760919. DOI: 10.1016/j.jpha.2012.09.001.
Kang J, Park Y, Kim S, Kim S, Jun M Korean J Physiol Pharmacol. 2011; 15(2):67-81.
PMID: 21660146 PMC: 3104201. DOI: 10.4196/kjpp.2011.15.2.67.
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.
Krasowski M Pharmaceuticals (Basel). 2010; 3(6):1909-1935.
PMID: 20640233 PMC: 2904466. DOI: 10.3390/ph3061909.